Crossmark

ASO Visual Abstract: Immunohistochemical Status Predicts Pathologic Complete Response to Neoadjuvant Therapy in HER2 Overexpressing Breast Cancers

Published Online: 2024-12-03

Published Print: 2025-02

Authors

Winer, Leah

Ruth, Karen J.

Bleicher, Richard J.

Nagarathinam, Rajeswari

McShane, Melissa

Porpiglia, Andrea S.

Pronovost, Mary T.

Aggon, Allison

Williams, Austin D.
License Information

Text and Data Mining valid from 2024-12-03

Version of Record valid from 2024-12-03
More Information

Article History

First Online: 3 December 2024

DISCLOSURE

: RJB, ASP, AA, and ADW are consultants for Elucent Medical.

Document is current